Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
20.11.23
/
50%
€5.05
Target price
20.11.24
€10.98
Performance (%)
102.67%
Price
17:56
€10.24
Summary
This prediction is currently active. With a performance of 102.67% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 20.11.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | -19.684% | -19.684% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€14.52
29.02.24
29.02.24
€19.38
28.02.25
28.02.25
-29.51%
17:56
17:56
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
20.02.24
20.02.24
€17.55
20.02.25
20.02.25
-13.26%
17:56
17:56